Breaking News Instant updates and real-time market news.

MO

Altria Group

$42.01

-0.77 (-1.80%)

, BTI

British American Tobacco

$36.76

-1.21 (-3.19%)

16:19
09/15/19
09/15
16:19
09/15/19
16:19

New York bans flavored e-cigarettes, Reuters reports

New York Governor Andrew Cuomo announced a ban on all flavored e-cigarettes besides tobacco and menthol in response to a recent nationwide spate of sometimes deadly lung illnesses that U.S. health officials have linked to vaping, according to Reuters. Publicly traded companies in the tobacco space include Altria Group (MO), British American Tobacco (BTI), Imperial Brands (IMBBY) and Philip Morris (PM). Juul, in which Altria Group has a 35% stake, is the dominant e-cigarette maker in the U.S. Reference Link

MO

Altria Group

$42.01

-0.77 (-1.80%)

BTI

British American Tobacco

$36.76

-1.21 (-3.19%)

IMBBY

Imperial Brands

$0.00

(0.00%)

PM

Philip Morris

$73.01

-1.89 (-2.52%)

  • 12

    Nov

MO Altria Group
$42.01

-0.77 (-1.80%)

09/12/19
SBSH
09/12/19
NO CHANGE
SBSH
E-vapor regulation to hit Juul hard, 'odd time' for merger talks, says Citi
The Trump Administration said yesterday that it will "clear" the market of all non-tobacco flavored e-vapor products, including mint and menthol, Citi analyst Adam Spielman tells investors in a research note. The analyst had hoped the rules would have little impact on Juul as it has stopped supplying fruit flavors to physical stores. However, Trump's proposal is likely to hit Juul hard, as about three-quarter of its volume is in mint, says Spielman. Further, he believes at least half of British American Tobacco's (BTI) and IImperial Brands' (IMBBY) e-vapor volumes in the U.S. will be banned under the new definition. This all reinforces that this is an "odd time" for Philip Morris (PM) and Altria Group (MO) to be in merger talks, contends Spielman. The analyst, who doubts Trump's announcement will affect the talks between the companies, says the future of tobacco regulation in the U.S. is unclear currently. "We can only assume the companies have chosen to talk now because they are very confident about the outcomes. We, by contrast, see plenty of risk," writes Spielman.
09/10/19
PIPR
09/10/19
DOWNGRADE
Target $49
PIPR
Neutral
Altria Group downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Michael Lavery downgraded Altria Group (MO) to Neutral from Overweight and lowered his price target for the shares to $49 from $64. Following discussions between Altria and Philip Morris (PM) of a potential merger of equals, the analyst has less confidence in Altria's outlook. The analyst says any interest in a deal without a premium could suggest more stress on the underlying fundamentals and management's outlook for the future than he had appreciated. Further, the analyst adds that while potential earnings from the Juul stake may be underappreciated, he's also less confident on Altria's approval from the FTC and FDA. He prefers more clarity from regulators before getting more bullish on the vapor outlook.
09/09/19
PIPR
09/09/19
DOWNGRADE
PIPR
Neutral
Altria Group downgraded to Neutral from Overweight at Piper Jaffray
09/12/19
JEFF
09/12/19
NO CHANGE
Target $71
JEFF
Hold
Jefferies lowers Philip Morris and Altria targets, sees little value in merger
Jefferies analyst Owen Bennett updated his estimates on Philip Morris (PM) and Altria Group (MO) post their results and his look at the possible merger in more detail. With a deal creating "little value in a best case scenario," the analyst thinks the merger "could also be a move driven to limit downside," with Juul possibly to be targeted by the FDA and/or the IQOS outlook globally not as strong as perceived. To reflect these risks, Bennett lowered his price target for Philip Morris to $71 from $82 and for Altria Group to $46 from $57. The analyst keeps Hold rating on both stocks.
BTI British American Tobacco
$36.76

-1.21 (-3.19%)

08/28/19
JPMS
08/28/19
NO CHANGE
JPMS
Neutral
Philip Morris selloff on Altria merger talks overdone, says JPMorgan
JPMorgan analyst Celine Pannuti views the selloff in shares of Philip Morris (PM) following confirmation of the company's merger talks with Altria Group (MO) as overdone. The deal leads to value accretion at no premium and U.S. regulatory risks are already embedded in the sector de-rating, Pannuti tells investors in a research note. The analyst also sees the weakness in British American Tobacco (BTI) shares as a buying opportunity. The consideration of a merger between Philip Morris and Altria is a vote of confidence in the U.S. combustibles profit pool, contrary to current market sentiment, says Pannuti. The analyst keeps a Neutral rating on Philip Morris with an $86 price target.
08/27/19
SBSH
08/27/19
NO CHANGE
SBSH
Citi sees no antitrust reason to stop Philip Morris, Altria deal
Citi analyst Adam Spielman is surprised by the merger talks between Philip Morris (MO) and Altria Group (MO) but feels the deal is likely to go ahead as he sees no antitrust reason to stop it. With the combined company likely a stronger competitor, the potential deal is not a positive for both British American Tobacco (BTI) and Imperial Brands (IMBBY), Spielman tells investors in a research note.
07/16/19
WELS
07/16/19
NO CHANGE
WELS
Wells says Nielsen restatement could be positive for Monster, tobacco stocks
Wells Fargo analyst Bonnie Herzog noted that Nielsen (NLSN) just announced that it will restate data to address serious issues with its calculation methodology in the convenience store channel related to projections it applied to independent c-stores. The restated data, to be released on August 20, is expected to improve cigarette and energy drink trends and she views this as a positive for tobacco stocks and Monster Beverage (MNST). Publicly traded companies in the tobacco space include Altria Group (MO), British American Tobacco (BTI) and Philip Morris (PM).
IMBBY Imperial Brands
$0.00

(0.00%)

05/28/19
SBSH
05/28/19
NO CHANGE
SBSH
Cigarette data from Nielsen 'dire,' industry data also 'very bad,' says Citi
Citi analyst Adam Spielman noted that Nielsen reported earlier today that cigarette industry volumes fell 11.2% in the four weeks ended May 18, noting that shares of Altria (MO), British American Tobacco (BTI) and Imperial (IMBBY) all fell following the "dire" data. Volumes in MSAi, the industry database that he regards as much more reliable than Nielsen, were down 6.4% in the same period, which Spielman said "is still a very bad figure, but it is a lot, lot better than the Nielsen one." Looking ahead, the analyst said he expects "gradually less bad" volumes in Nielsen in the rest of the year, though he noted that Altria has said it expects industry volumes to fall about 4%-5% this year and he forecasts a decline of about 6%. In late afternoon trading, Altria shares are down 4.5%, British American has declined over 4% and Philip Morris (PM) is down 5%.
03/28/19
SBSH
03/28/19
UPGRADE
SBSH
Buy
Imperial Brands upgraded to Buy from Neutral at Citi
Citi analyst Adam Spielman upgraded Imperial Brands to Buy from Neutral and raised his price target for the shares to GBP 30 from GBP 27. The analyst believes organic revenue growth for tobacco companies will pick up this year as sales of next generation products accelerate. Further, the regulatory threat will probably move away from cigarettes, Spielman tells investors in a research note. He thinks an even greater focus on e-vapor cigarettes could be positive for both British American Tobacco and Imperial Brands.
PM Philip Morris
$73.01

-1.89 (-2.52%)

09/05/19
MSCO
09/05/19
NO CHANGE
MSCO
Morgan Stanley sees little merit in recombining Philip Morris with Altria
Morgan Stanley analyst Pamela Kaufman believes much of the rationale behind Philip Morris (PM) and Altria's (MO) split in 2008 remains valid and she sees little strategic or financial merit in a potential recombination, which the companies have confirmed they are discussing via a possible all-stock merger of equals. Gaining full control of IQOS in the U.S. does not justify such a transaction and while Philip Morris may be interested in buying Altria to gain exposure to JUUL, Kaufman noted that the former would also inherit the latter's noncompete with JUUL in vaping, impacting its ability to sell other e-cigs. Also, it is unclear if JUUL will be able to replicate its success internationally and there is significant risk in the U.S. given uncertainty around JUUL's FDA approval, she believes. Kaufman has an Equal Weight rating on Altria shares and an Overweight rating on Philip Morris International.

TODAY'S FREE FLY STORIES

PBI

Pitney Bowes

$4.40

0.04 (0.92%)

09:13
10/14/19
10/14
09:13
10/14/19
09:13
Hot Stocks
Pitney Bowes issues statement on malware attack »

Pitney Bowes issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

INFY

Infosys

$10.97

-0.22 (-1.97%)

09:13
10/14/19
10/14
09:13
10/14/19
09:13
Downgrade
Infosys rating change  »

Infosys downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

ARGO

Argo Group

$67.34

1.4 (2.12%)

09:12
10/14/19
10/14
09:12
10/14/19
09:12
Hot Stocks
Argo Group holder Voce comments on SEC probe »

Voce Capital, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARW

Arrow Electronics

$74.22

1.095 (1.50%)

, TXN

Texas Instruments

$130.08

2.52 (1.98%)

09:11
10/14/19
10/14
09:11
10/14/19
09:11
Recommendations
Arrow Electronics, Texas Instruments analyst commentary  »

Longbow says Arrow…

ARW

Arrow Electronics

$74.22

1.095 (1.50%)

TXN

Texas Instruments

$130.08

2.52 (1.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

BKI

Black Knight

$61.68

0.39 (0.64%)

09:11
10/14/19
10/14
09:11
10/14/19
09:11
Hot Stocks
Black Knight receives to patents from USPTO »

Black Knight announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

UPS

UPS

$116.06

0.76 (0.66%)

09:10
10/14/19
10/14
09:10
10/14/19
09:10
Hot Stocks
UPS launches Storage on Demand service »

UPS announced the launch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

HON

Honeywell

$163.52

2.63 (1.63%)

09:09
10/14/19
10/14
09:09
10/14/19
09:09
Hot Stocks
Honeywell finalizing new T55 engine to power U.S. Army's Chinook helicopters »

Honeywell is finalizing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

OKTA

Okta

$116.19

1.65 (1.44%)

, PING

Ping Identity

$16.47

0.45 (2.81%)

09:09
10/14/19
10/14
09:09
10/14/19
09:09
Initiation
Okta, Ping Identity, Zscaler, Crowdstrike initiated  »

Citi expands Software…

OKTA

Okta

$116.19

1.65 (1.44%)

PING

Ping Identity

$16.47

0.45 (2.81%)

ZS

Zscaler

$48.16

0.81 (1.71%)

CRWD

Crowdstrike

$60.24

-1.08 (-1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 19

    Nov

  • 12

    Dec

  • 16

    Dec

ERIC

Ericsson

$8.44

0.2 (2.43%)

09:09
10/14/19
10/14
09:09
10/14/19
09:09
Hot Stocks
Ericsson and Watch Communications enter into partnership »

Watch Communications has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

OSTK

Overstock.com

$10.67

-0.18 (-1.66%)

09:08
10/14/19
10/14
09:08
10/14/19
09:08
Hot Stocks
Medici Land Governance signs MOU with St. Kitts and Nevis government »

Overstock.com announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMTL

Comtech

$31.24

0.51 (1.66%)

09:08
10/14/19
10/14
09:08
10/14/19
09:08
Hot Stocks
Comtech awarded $4.4M contract renewal »

Comtech announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RETA

Reata Pharmaceuticals

$95.80

9.86 (11.47%)

09:08
10/14/19
10/14
09:08
10/14/19
09:08
Recommendations
Reata Pharmaceuticals analyst commentary  »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$20.76

0.76 (3.80%)

09:06
10/14/19
10/14
09:06
10/14/19
09:06
Recommendations
Wendy's analyst commentary  »

Wendy's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

  • 13

    Nov

LAND

Gladstone Land

$11.87

(0.00%)

09:06
10/14/19
10/14
09:06
10/14/19
09:06
Hot Stocks
Gladstone Land clarifies certain aspects of external fee structure »

Gladstone Land offered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

LMAT

LeMaitre

$31.29

-0.03 (-0.10%)

09:06
10/14/19
10/14
09:06
10/14/19
09:06
Hot Stocks
Admedus sells CardioCel, VascuCel patch business to LeMaitre for $A36.2M »

Admedus announces the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

HUBS

HubSpot

$163.05

2.975 (1.86%)

09:05
10/14/19
10/14
09:05
10/14/19
09:05
Recommendations
HubSpot analyst commentary  »

Enterprise, sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

GWPH

GW Pharmaceuticals

$114.35

-3.8 (-3.22%)

09:04
10/14/19
10/14
09:04
10/14/19
09:04
Recommendations
GW Pharmaceuticals analyst commentary  »

Investor concerns related…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 05

    Nov

LAND

Gladstone Land

$11.87

(0.00%)

09:04
10/14/19
10/14
09:04
10/14/19
09:04
Hot Stocks
Gladstone Land says 'hopeful' China plan will make 'Midwest growers stronger' »

Gladstone Land…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

LMAT

LeMaitre

$31.29

-0.03 (-0.10%)

09:03
10/14/19
10/14
09:03
10/14/19
09:03
Hot Stocks
Breaking Hot Stocks news story on LeMaitre »

Admedus sells CardioCel,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ABT

Abbott

$79.61

0.11 (0.14%)

09:02
10/14/19
10/14
09:02
10/14/19
09:02
Hot Stocks
Abbott and Omada Health announce partnership »

Abbott and Omada Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

XGN

Exagen

$12.18

-1.17 (-8.76%)

09:00
10/14/19
10/14
09:00
10/14/19
09:00
Initiation
Exagen initiated  »

Exagen initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOOP

Loop Industries

$10.39

0.01 (0.10%)

08:56
10/14/19
10/14
08:56
10/14/19
08:56
Initiation
Loop Industries initiated  »

Loop Industries initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

Jeld-Wen

$16.08

-2.56 (-13.73%)

08:55
10/14/19
10/14
08:55
10/14/19
08:55
Recommendations
Jeld-Wen analyst commentary  »

Jeld-Wen price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

AAPL

Apple

$236.21

6.12 (2.66%)

, BAC

Bank of America

$28.90

0.46 (1.62%)

08:55
10/14/19
10/14
08:55
10/14/19
08:55
Options
Notable open interest changes for October 14th »

Friday's total…

AAPL

Apple

$236.21

6.12 (2.66%)

BAC

Bank of America

$28.90

0.46 (1.62%)

FB

Facebook

$184.20

4.02 (2.23%)

TSLA

Tesla

$247.84

3.14 (1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

  • 30

    Oct

  • 12

    Nov

ZG

Zillow

$29.25

0.52 (1.81%)

08:50
10/14/19
10/14
08:50
10/14/19
08:50
Recommendations
Zillow analyst commentary  »

Zillow's Flex, PA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.